Showing results (141-150 of 757) with videos related to

Sort By:
Pageof 76
The Lancet. Gastroenterology & Hepatology|May 13, 2017
Long-term challenges and perspectives of pre-adolescent liver diseaseNedim Hadžić, Ulrich Baumann, Pat McKiernan, et al.
The Lancet. Gastroenterology & Hepatology|May 13, 2017
The intestinal microbiome and paediatric liver diseaseDaniel H Leung, Dean Yimlamai
The Lancet. Gastroenterology & Hepatology|May 13, 2017
Beyond the Milan criteria for liver transplantation in children with hepatic tumoursJean de Ville de Goyet, Rebecka L Meyers, Greg M Tiao, et al.
The Lancet. Gastroenterology & Hepatology|April 8, 2018
Safety and efficacy of preoperative or postoperative chemotherapy for resectable pancreatic adenocarcinoma (PACT-15): a randomised, open-label, phase 2-3 trialMichele Reni, Gianpaolo Balzano, Silvia Zanon, et al.
The Lancet. Gastroenterology & Hepatology|July 11, 2017
Country, regional, and global estimates for lactose malabsorption in adults: a systematic review and meta-analysisChristian Løvold Storhaug, Svein Kjetil Fosse, Lars T Fadnes
The Lancet. Gastroenterology & Hepatology|July 11, 2017
Pancreaticobiliary maljunction and congenital biliary dilatationTerumi Kamisawa, Kenitiro Kaneko, Takao Itoi, et al.
The Lancet. Gastroenterology & Hepatology|June 13, 2018
Non-alcoholic fatty liver disease and the interface between primary and secondary careEmmanuel A Tsochatzis, Philip N Newsome
The Lancet. Gastroenterology & Hepatology|March 2, 2023
One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trialKara L Kliewer, Nirmala Gonsalves, Evan S Dellon, et al.
The Lancet. Gastroenterology & Hepatology|December 5, 2025
Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trialMilind Javle, Christos Fountzilas, Chih-Yi Liao, et al.
The Lancet. Gastroenterology & Hepatology|January 22, 2026
Cyclic exclusive enteral nutrition versus partial enteral nutrition to maintain long-term drug-free remission in paediatric Crohn's disease (CD-HOPE): an open-label, endpoint-blinded, randomised controlled trialBénédicte Pigneur, Christine Martinez-Vinson, Aurélie Bourmaud, et al.
Pageof 76